Search Results 231-240 of 707 for ������������������������ ������������KaKaotalk:PC53���24������ ���������������

  1. A Study to Assess the Effectiveness, Safety, Tolerability, and Drug/Body Interactions of ABBV-8E12 in Progressive Supranuclear Palsy - Mayo Clinic

    The purpose of this study is to assess the effectiveness, safety, tolerability, and drug/body interactions of ABBV-8E12 for the treatment of patients who have ...

  2. An Efficacy and Safety Trial of MK-8931 in Mild to Moderate Alzheimer's Disease (P07738) - Mayo Clinic

    The purpose of Part I of the study is to assess the efficacy and safety of MK-8931 compared with placebo administered for 78 weeks in the treatment of ...

  3. Effect of TAK-954 on Gastrointestinal and Colonic Transit in Diabetic or Idiopathic Gastroparesis Participants - Mayo Clinic

    The purpose of this study is to evaluate the dose-dependent effects of TAK-954 on gastric emptying time of solids in participants with diabetic or idiopathic ...

  4. Examining Alaska Native peoples' perspectives about options for colorectal cancer screening - Mayo Clinic

    Survey results provided valuable insights into the complex factors influencing colorectal cancer (CRC) screening preferences in high-risk, ...

  5. Virtual colonoscopy - Mayo Clinic

    Unlike other colon cancer screening tests, this imaging test doesn't use a scope to examine your colon. Learn how it works and what to expect.

  6. T Cell Lymphoma Clinical Trials - Mayo Clinic Research

    Giving chemotherapy before a stem cell transplant helps kill cancer cells in the body and helps make room in the patient's bone marrow for new blood-forming ...

  7. Clinical trials - Oncology (Medical)

    Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

  8. A Study to Test Adding Pembrolizumab to Olaparib Alone as Therapy for Patients with Pancreatic Cancer That Has Spread with Inherited BRCA Mutations - Mayo Clinic

    Patients must have received at least 16 weeks but no more than 24 weeks of first line platinum-based therapy for metastatic disease. Patients' last ...

  9. A Study to Evaluate the Effectiveness and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. A Study to Evaluate Virtual Remote Control Robotic Percutaneous Coronary Intervention - Mayo Clinic

    The purpose of this study is to evaluate whether or not robotic percutaneous coronary interventin (PCI) can be performed safely and effectively with the primary ...